International Journal of Indian Medicine

ISSN: 0000-0000

Year: 2021 |Volume: 2 | Issue: 01


Clinical Study of Tindukamrita capsule with Nirgundi Patra Panda Sweda in the management on Amavata

About Author

Shakuntala Sundi1 , V.D. Shukla2 , Rajan Nelson Munzni3 , Sushma Khalkho4

1MD, department of kayachikitsa, IPGT and RA, GAU, senior medical officer in Jharkhand Govt.

2MD PhD, EX-HOD, department of panch akarma, IPGT and RA, GAU, Jamnagar

33. MD., Ph.D. Associate Professor, Dept. of PanchaKarma (In-charge), G.A.S.A.C.H., Begusarai (Bihar)

4MD, department of Shalya Tantra, NIA, Jaipur


Date of Acceptance: 2021-01-05

Date of Publication:2021-02-10

Correspondence Address:

Dr. Shakuntala Sundi - MD, department of kayachikitsa, IPGT and RA, GAU, senior medical officer in Jharkhand Govt. Email -Sundisakuntala@gmail.com
Article-ID:IJIM_48_02_21 https://ijim.co.in

Keywords: Nirgundi Patra Pinda Sweda, Tindukamrita capsule, Amavata, Rheumatoid arthritis


Source of Support: NIL

Conflict of Interest: NIL


Abstract


There are so many dreadful diseases prevalent in medical science. The scopes of therapeutic measures are limited even extreme advancement of modern bio-medical sciences. The Rheumatological disorder is such a group of diseases which has no specific medical management in any type of therapeuties Amavata is the particular type of disease which is the mentioned in Ayurveda since the period of Madhavakara under the category of vata-kaphaja disorders. The Ayurvedic approach to the treatment is the need of our as no system is successful in providing the complete cure to the Rheumatological disorder. Still Amavata is a challenging and a burning problem of medical science. In this research work 27 patients were registered from OPD and IPD of IPGT and RA, these patients were given Tindukamrita capsule in the doses of 500gm two capsule three times a day for 30 days, along with Nirgundi Patra Pinda Sweda in 28 days. Results shows that significant decrease in the sign and symptoms of Amavata after treatment regimen.